American registry of pathology expert opinions: The spectrum of lobular carcinoma in situ: Diagnostic features and clinical implications Review

   


Authors: Schnitt, S. J.; Brogi, E.; Chen, Y. Y.; King, T. A.; Lakhani, S. R.
Review Title: American registry of pathology expert opinions: The spectrum of lobular carcinoma in situ: Diagnostic features and clinical implications
Abstract: This review reflects a collaboration between the American Registry of Pathology (the publisher of the Armed Forces Institute of Pathology Fascicles) and Annals of Diagnostic Pathology. It is part of a series of expert recommendations on topics encountered in daily practice. The authors, 4 pathologists with expertise in breast pathology and a breast surgeon with a clinical and research interest in lobular carcinoma in situ (LCIS), met by conference call in September 2019 to develop recommendations for evaluating and reporting LCIS. Herein, we summarize the diagnostic criteria of classic LCIS and LCIS subtypes according to the most recent WHO criteria, discuss how best to distinguish LCIS from ductal carcinoma in situ in problematic cases (including the uses and limitations of E-cadherin immunohistochemistry), and review outcome and management issues for patients with LCIS. © 2020 Elsevier Inc.
Journal Title: Annals of Diagnostic Pathology
Volume: 45
ISSN: 1092-9134
Publisher: Elsevier Inc.  
Date Published: 2020-04-01
Start Page: 151481
Language: English
DOI: 10.1016/j.anndiagpath.2020.151481
PROVIDER: scopus
PUBMED: 32120324
PMCID: PMC7401835
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080031189&doi=10.1016%2fj.anndiagpath.2020.151481&partnerID=40&md5=d6ff313c07e0b5b5d7f78b4869c50412
Notes: Review -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Edi Brogi
    515 Brogi
Related MSK Work